R24AG064025/AG/NIA NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2020	1
2021	4
2022	4
2023	9
2024	11

1

Measuring Quality of Life in Deprescribing Trials: A Scoping Review.

Thompson W, Lundby C, Bleik A, Waring H, Hong JA, Xi C, Hughes C, Salzwedel DM, McDonald EG, Pruskowski J, Scott S, Spinewine A, Kutner JS, Graabæk T, Elmi S, Moriarty F. Thompson W, et al. Drugs Aging. 2024 May;41(5):379-397. doi: 10.1007/s40266-024-01113-0. Epub 2024 May 6. Drugs Aging. 2024. PMID: 38709466 Review.

2

Polypharmacy among older adults with dementia compared with those without dementia in the United States.

Growdon ME, Gan S, Yaffe K, Steinman MA. Growdon ME, et al. J Am Geriatr Soc. 2021 Sep;69(9):2464-2475. doi: 10.1111/jgs.17291. Epub 2021 Jun 8. J Am Geriatr Soc. 2021. PMID: 34101822 Free PMC article.

3

Optimizing Medication Use in Older Adults With Rheumatic Musculoskeletal Diseases: Deprescribing as an Approach When Less May Be More.

Lee J, Singh N, Gray SL, Makris UE. Lee J, et al. ACR Open Rheumatol. 2022 Dec;4(12):1031-1041. doi: 10.1002/acr2.11503. Epub 2022 Oct 24. ACR Open Rheumatol. 2022. PMID: 36278868 Free PMC article. Review.

4

Deprescribing and deimplementation: Time for transformative change.

Steinman MA, Boyd CM, Spar MJ, Norton JD, Tannenbaum C. Steinman MA, et al. J Am Geriatr Soc. 2021 Dec;69(12):3693-3695. doi: 10.1111/jgs.17441. Epub 2021 Sep 9. J Am Geriatr Soc. 2021. PMID: 34499742 Free PMC article. No abstract available.

5

Clinical Utility of Medication-Based Risk Scores to Reduce Polypharmacy and Potentially Avoidable Healthcare Utilization.

Silva-Almodóvar A, Nahata MC. Silva-Almodóvar A, et al. Pharmaceuticals (Basel). 2022 May 28;15(6):681. doi: 10.3390/ph15060681. Pharmaceuticals (Basel). 2022. PMID: 35745600 Free PMC article.

6

High opioid doses, naloxone, and central nervous system active medications received by Medicare-enrolled adults.

Silva Almodóvar A, Nahata MC. Silva Almodóvar A, et al. J Am Geriatr Soc. 2023 Jan;71(1):98-108. doi: 10.1111/jgs.18102. Epub 2022 Oct 26. J Am Geriatr Soc. 2023. PMID: 36289563 Free PMC article.

7

The Patient Typology about deprescribing and medication-related decisions: A quantitative exploration.

Weir KR, Scherer AM, Vordenberg SE, Streit S, Jansen J, Jungo KT. Weir KR, et al. Basic Clin Pharmacol Toxicol. 2024 Jan;134(1):39-50. doi: 10.1111/bcpt.13911. Epub 2023 Jul 3. Basic Clin Pharmacol Toxicol. 2024. PMID: 37300477 Free article.

8

Deprescribing medications among patients with multiple prescribers: A socioecological model.

Silva Almodóvar A, Keller MS, Lee J, Mehta HB, Manja V, Nguyen TPP, Pavon JM, Terman SW, Hoyle D, Mixon AS, Linsky AM. Silva Almodóvar A, et al. J Am Geriatr Soc. 2024 Mar;72(3):660-669. doi: 10.1111/jgs.18667. Epub 2023 Nov 9. J Am Geriatr Soc. 2024. PMID: 37943070 Free PMC article.

9

A Qualitative Study of Perspectives of Older Adults on Deintensifying Diabetes Medications.

Pilla SJ, Meza KA, Schoenborn NL, Boyd CM, Maruthur NM, Chander G. Pilla SJ, et al. J Gen Intern Med. 2023 Mar;38(4):1008-1015. doi: 10.1007/s11606-022-07828-3. Epub 2022 Sep 29. J Gen Intern Med. 2023. PMID: 36175758 Free PMC article.

10

The future of deprescribing research: Seizing opportunities and learning from the past.

Steinman MA. Steinman MA. Basic Clin Pharmacol Toxicol. 2023 Dec;133(6):653-656. doi: 10.1111/bcpt.13852. Epub 2023 Mar 14. Basic Clin Pharmacol Toxicol. 2023. PMID: 36916220 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

21 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year